These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20213097)

  • 1. DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
    Cheng HY; Chen XW; Cheng L; Liu YD; Lou G
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1821-5. PubMed ID: 20213097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.
    Cheng HY; Gao Y; Lou G
    Eur J Med Res; 2010 Jan; 15(1):20-4. PubMed ID: 20159667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
    Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
    Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells.
    Tan SX; Hu RC; Liu JJ; Tan YL; Liu WE
    Int J Clin Exp Pathol; 2014; 7(5):2305-11. PubMed ID: 24966940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
    Lal G; Padmanabha L; Smith BJ; Nicholson RM; Howe JR; O'Dorisio MS; Domann FE
    Cancer; 2006 Dec; 107(12):2752-9. PubMed ID: 17103461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
    Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
    PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGSF4 promoter methylation and expression silencing in human cervical cancer.
    Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
    Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma.
    Tan SX; Hu RC; Tan YL; Liu JJ; Liu WE
    Tumour Biol; 2014 May; 35(5):4509-16. PubMed ID: 24395656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
    Song Y; Zhang C
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.
    Shu XS; Geng H; Li L; Ying J; Ma C; Wang Y; Poon FF; Wang X; Ying Y; Yeo W; Srivastava G; Tsao SW; Yu J; Sung JJ; Huang S; Chan AT; Tao Q
    PLoS One; 2011; 6(11):e27346. PubMed ID: 22087297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
    Yang WT; Zheng PS
    PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent hypermethylation of 5' flanking region of TIMP-2 gene in cervical cancer.
    Ivanova T; Vinokurova S; Petrenko A; Eshilev E; Solovyova N; Kisseljov F; Kisseljova N
    Int J Cancer; 2004 Mar; 108(6):882-6. PubMed ID: 14712492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.